BCN today announced the commencement of its exploration campaign. The campaign will be fully funded by the proceeds from the Jaurdi mill, which is currently projected to produce ~ 26,400 oz for the financial year, with an estimated revenue of ~$71m based on a realised spot price of $2750 per oz, and an existing hedge book for 5,000 oz at an average of $2,507 oz. This production is projected to net the company circa $42m based on cash cost (inc royalty) of $1,052 oz and a sustaining cost of $50 oz. Further reductions to the cash cost are expected to be realised over the coming year.
Company Snapshot:
Current price: $0.037
Market cap: $106m
SOI: 2.86bn
Options on issue: 936m
Projected profit FY21: $42m
Cash on Hand at June 30th 2020: $15m
Cash equivalents at June 30th 2020: $3m
Debt: $18m
Net Debt: $0
Current LOM ~4 years @ 26k oz p/aHotcopper Link to announcement
- Forums
- ASX - By Stock
- BCN
- Exploration commencing August 2020
BCN
beacon minerals limited
Add to My Watchlist
7.14%
!
2.6¢

Exploration commencing August 2020
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.6¢ |
Change
-0.002(7.14%) |
Mkt cap ! $109.8M |
Open | High | Low | Value | Volume |
2.8¢ | 2.8¢ | 2.6¢ | $186.3K | 7.097M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 2792466 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 177375 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 2092466 | 0.026 |
5 | 2150000 | 0.025 |
1 | 1000000 | 0.024 |
3 | 1352822 | 0.021 |
2 | 2025000 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 1016741 | 2 |
0.030 | 1693785 | 6 |
0.031 | 2295360 | 13 |
0.032 | 1263802 | 9 |
0.033 | 1911971 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
BCN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online